abrdn plc lifted its holdings in Teleflex Incorporated (NYSE:TFX – Get Rating) by 7.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,969 shares of the medical technology company’s stock after acquiring an additional 872 shares during the period. abrdn plc’s holdings in Teleflex were worth $3,237,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently made changes to their positions in TFX. Vanguard Group Inc. boosted its holdings in shares of Teleflex by 2.1% during the 3rd quarter. Vanguard Group Inc. now owns 5,339,526 shares of the medical technology company’s stock worth $1,075,700,000 after buying an additional 110,456 shares in the last quarter. State Street Corp boosted its stake in Teleflex by 3.0% during the third quarter. State Street Corp now owns 2,035,739 shares of the medical technology company’s stock worth $410,120,000 after acquiring an additional 58,500 shares in the last quarter. Ceredex Value Advisors LLC grew its holdings in Teleflex by 12.6% in the third quarter. Ceredex Value Advisors LLC now owns 877,887 shares of the medical technology company’s stock worth $176,859,000 after purchasing an additional 98,363 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Teleflex by 119.3% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 803,403 shares of the medical technology company’s stock valued at $200,553,000 after purchasing an additional 437,083 shares in the last quarter. Finally, TD Asset Management Inc. boosted its position in shares of Teleflex by 2.0% during the 3rd quarter. TD Asset Management Inc. now owns 532,817 shares of the medical technology company’s stock worth $108,679,000 after purchasing an additional 10,531 shares in the last quarter. 93.82% of the stock is owned by institutional investors.
Teleflex Stock Performance
Shares of TFX stock opened at $237.27 on Wednesday. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.41 and a current ratio of 2.48. The firm has a market cap of $11.13 billion, a price-to-earnings ratio of 30.93, a P/E/G ratio of 2.61 and a beta of 1.00. Teleflex Incorporated has a 52 week low of $182.65 and a 52 week high of $290.95. The firm’s 50-day simple moving average is $254.48 and its two-hundred day simple moving average is $244.17.
Teleflex Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 15th. Shareholders of record on Monday, May 15th will be issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.57%. The ex-dividend date of this dividend is Friday, May 12th. Teleflex’s dividend payout ratio (DPR) is presently 17.73%.
Insiders Place Their Bets
In other news, Director Stuart A. Randle sold 3,021 shares of the business’s stock in a transaction that occurred on Wednesday, May 10th. The shares were sold at an average price of $245.71, for a total value of $742,289.91. Following the sale, the director now owns 4,847 shares of the company’s stock, valued at $1,190,956.37. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 1.41% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on TFX shares. JMP Securities reissued a “market outperform” rating and issued a $330.00 price objective on shares of Teleflex in a research note on Thursday, March 30th. Needham & Company LLC reissued a “buy” rating and set a $291.00 target price on shares of Teleflex in a research report on Friday, February 24th. StockNews.com initiated coverage on Teleflex in a research note on Thursday, May 18th. They set a “buy” rating for the company. Truist Financial raised their target price on Teleflex from $250.00 to $264.00 and gave the company a “hold” rating in a report on Monday, April 17th. Finally, Wolfe Research lowered Teleflex from an “outperform” rating to a “peer perform” rating in a research report on Wednesday, April 26th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and an average target price of $271.75.
Teleflex Profile
Teleflex, Inc provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
Featured Stories
- Get a free copy of the StockNews.com research report on Teleflex (TFX)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Get Rating).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
